Avonex
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Introduction: Multiple sclerosis is a chronic and degenerative neurological disease characterized by loss of myelin sheath of…
Background Once-a-Week-Avonex Syringe(30 μg Interferon beta-1a Intramuscular)was approved in Japan in November 2006 for the…
Authors have followed up 230 patients with multiple sclerosis treated with disease modifying drugs (DMD) using the data of the…
To evaluate clinical perspectives of proton multi-voxel magnetic-resonance spectroscopy (PMMRS) for monitoring the severity of…
The administration of β-interferon is a recognized treatment for multiple sclerosis. The frequency of side effects is an…